DUBLIN--(BUSINESS WIRE)--The "Biopsy Devices Market, Global Forecast by Products (Needles, Guidance Systems, Guns Reagents), Regions, Application and Companies" report has been added to ResearchAndMarkets.com's offering.
The factors that drive the biopsy market globally are the growing prevalence of cancer, as well as an inclination towards minimally invasive surgeries and the rising geriatric populace. Some of the growth factors of this market were growing awareness among public as well as discoveries in newer technologies.
This report provides a detailed analysis of the global biopsy devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future.
On the basis of application, Lung Biopsy and Breast Biopsy markets together dominate the market share of Biopsy Devices Market globally. Although, the Prostate Biopsy market share is growing annually at a significant rate.
On the basis of regions, North America and Europe together capture the market share of the Biopsy Devices Market globally. At the same time, the Asia-Pacific region is projected to grow more rapidly over the projected time period.
The key players in this industry include C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Hologic, Inc. The company focuses on the development of new products, partnerships and acquisitions to maintain their positions in the market.
All the 8 Companies Studied in the Report Have Been Studied From 4 Points:
- Merger & Acquisition
Biopsy Segments Covered in the Report:
- Biopsy Needles
- Guidance Systems
- Biopsy Guns
- Reagents and kits
For more information about this report visit https://www.researchandmarkets.com/research/zgnm84/global_biopsy?w=4